Bimal R. Shah
Independent DirectorMr. Bimal R. Shah is Managing Director of San Francisco of Locust Walk Partners, LLC. He served as Chief Financial Officer at Corium, Inc since 2022 until March 2024. He joined Corium, Inc since 2022. He is Independent Director of Anebulo Pharmaceuticals, Inc. since October 2023. He served as Vice President of Corporate and Business Development at Spectrum Pharmaceuticals, Inc. and served as its Vice President of Finance - Business Development. Mr. Shah previously held business development, finance and strategic commercial roles at Genentech Inc. (part of Roche). Mr. Shah serves as the Chief Financial Officer and Treasurer at Allos Therapeutics, Inc. Mr. Shah was an Associate at Warburg Pincus LLC. He worked at New York office and was a Member of Healthcare and Biotechnology Group. Prior to joining Warburg Pincus in 2005, Mr. Shah was employed in the healthcare investment-banking group at Goldman, Sachs & Co. where he worked on mergers and acquisitions, debt and equity offerings. Mr. Shah was an Associate at J.P. Morgan Partners, LLC and Genetech in business development and strategy. Mr. Shah received his Master's in Business Administration, Master of Arts in International Policy Studies and Bachelor's of Arts in Economics from Stanford University.
Positions
- Company NameAnebulo Pharmaceuticals, Inc.Stock CodeANEBPositionIndependent Director
